(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and ...

BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

Pfizer and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...

Pfizer offers a dividend yield over 7%, but it's payout probably won't rise very fast in the decade ahead. Investors seeking ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Fauci spoke with On Point’s Meghna Chakrabarti at the WBUR Festival about the lessons learned from the COVID-19 pandemic and ...

Jim Cramer recently endorsed Pfizer, excited by its cancer-fighting potential and robust drug pipeline. A caller praised ...